Physician profile
Michael A Egger
NPI 1427047273
$921.86
in general payments reported to CMS, 2019-2025
12 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Pediatrics (Optometrist) provider received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.34 · 2020: $8.34 · 2021: $117 · 2022: $190 · 2023: $76.76 · 2024: $317 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $243.69 | 2022-2025 | Total30 |
| Novartis Pharmaceuticals Corporation | $174.41 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $136.15 | 2021-2025 | Cequa |
| Lkc Technologies, INC. | $95.63 | 2024-2025 | |
| Optos, INC. | $55.50 | 2019 | |
| Bausch & Lomb Americas INC. | $53.10 | 2024 | Vyzulta, Miebo, Xiidra |
| Oyster Point Pharma, INC. | $52.85 | 2023-2024 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $37.05 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $28.70 | 2021 | |
| Maculogix, INC. | $16.18 | 2019-2020 | |
| Thea Pharma INC. | $14.54 | 2024 | Iyuzeh |
| Allergan, INC. | $14.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Egger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.